Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872. https://doi.org/10.1200/jco.2004.12.149
Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14(1):48–54. https://doi.org/10.1007/s11912-011-0203-y
Brown PD et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316(4):401–409. https://doi.org/10.1001/jama.2016.9839
Article PubMed PubMed Central Google Scholar
Aoyama H et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483–2491.
Article CAS PubMed Google Scholar
Chang EL et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044. https://doi.org/10.1016/s1470-2045(09)70263-3
Trifiletti DM et al (2015) Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response. J Neurooncol 125(2):385–392. https://doi.org/10.1007/s11060-015-1927-6
Prasad S et al (2024) Outcomes of gamma knife radiosurgery for brain metastases in the motor cortex. Neurosurgery 94(3):606–613. https://doi.org/10.1227/neu.0000000000002716
Sneed PK et al (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123(2):373–386. https://doi.org/10.3171/2014.10.Jns141610
Luther N, Kondziolka D, Kano H, Mousavi SH, Flickinger JC, Lunsford LD (2013) Motor function after stereotactic radiosurgery for brain metastases in the region of the motor cortex. J Neurosurg 119(3):683–688. https://doi.org/10.3171/2013.6.Jns122081
Kancharla P, Ivanov A, Chan S, Ashamalla H, Huang RY, Yanagihara TK (2019) The effect of brain metastasis location on clinical outcomes: a review of the literature. Neurooncol Adv 1(1):vdz017. https://doi.org/10.1093/noajnl/vdz017
Article PubMed PubMed Central Google Scholar
Gonzalez Castro LN, Milligan TA (2020) Seizures in patients with cancer. Cancer 126(7):1379–1389. https://doi.org/10.1002/cncr.32708
Williams BJ et al (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111(3):439–448. https://doi.org/10.3171/2008.11.Jns08984
Lerner EC et al (2022) Factors associated with new-onset seizures following stereotactic radiosurgery for newly diagnosed brain metastases. Adv Radiat Oncol 7(6):101054. https://doi.org/10.1016/j.adro.2022.101054
Article CAS PubMed PubMed Central Google Scholar
Miller MS et al (2023) Seizure outcomes following single-fraction versus hypofractionated radiosurgery for brain metastases: a single-center experience. J Neurosurg 139(4):925–933. https://doi.org/10.3171/2023.2.Jns222778
Chen CC, Rennert RC, Olson JJ (2019) Congress of neurological surgeons systematic review and evidence-based guidelines on the role of prophylactic anticonvulsants in the treatment of adults with metastatic brain tumors. Neurosurgery 84(3):E195–e197. https://doi.org/10.1093/neuros/nyy545
Wali AR, Rennert RC, Wang SG, Chen CC (2021) Evidence-based recommendations for seizure prophylaxis in patients with brain metastases undergoing stereotactic radiosurgery. Acta Neurochir Suppl 128:51–55. https://doi.org/10.1007/978-3-030-69217-9_6
Minniti G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48. https://doi.org/10.1186/1748-717x-6-48
Article PubMed PubMed Central Google Scholar
Milano MT et al (2021) Single- and multifraction stereotactic radiosurgery dose/volume tolerances of the brain. Int J Radiat Oncol Biol Phys 110(1):68–86. https://doi.org/10.1016/j.ijrobp.2020.08.013
Hall J et al (2023) Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy. Radiother Oncol 189:109920. https://doi.org/10.1016/j.radonc.2023.109920
Article CAS PubMed Google Scholar
Kroeze SG et al (2017) Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review. Cancer Treat Rev 53:25–37. https://doi.org/10.1016/j.ctrv.2016.11.013
Hirsch I, Goldstein DA, Tannock IF, Butler MO, Gilbert DC (2022) Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access. Nat Med 28(11):2236–2237. https://doi.org/10.1038/s41591-022-02029-1
Article CAS PubMed Google Scholar
Eisenhauer EA et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. https://doi.org/10.1016/j.ejca.2008.10.026
Article CAS PubMed Google Scholar
Forsyth PA et al (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30(2):106–112. https://doi.org/10.1017/s0317167100053361
Lin NU et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270–278. https://doi.org/10.1016/s1470-2045(15)70057-4
Hsu F, Nichol A, Ma R, Kouhestani P, Toyota B, McKenzie M (2015) Stereotactic radiosurgery for metastases in eloquent central brain locations. Can J Neurol Sci 42(5):333–337. https://doi.org/10.1017/cjn.2015.55
Trifiletti DM, Lee CC, Shah N, Patel NV, Chen SC, Sheehan JP (2016) How does brainstem involvement affect prognosis in patients with limited brain metastases? Results of a matched-cohort analysis. World Neurosurg 88:563–568. https://doi.org/10.1016/j.wneu.2015.10.089
Dabrowska N et al (2019) Parallel pathways of seizure generalization. Brain 142(8):2336–2351. https://doi.org/10.1093/brain/awz170
Article PubMed PubMed Central Google Scholar
Sours Rhodes C et al (2019) The feasibility of integrating resting-state fmri networks into radiotherapy treatment planning. J Med Imaging Radiat Sci 50(1):119–128. https://doi.org/10.1016/j.jmir.2018.09.003
Miller JA et al (2016) Association between radiation necrosis and tumor biology after stereotactic radiosurgery for brain metastasis. Int J Radiat Oncol Biol Phys 96(5):1060–1069. https://doi.org/10.1016/j.ijrobp.2016.08.039
Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77(4):996–1001. https://doi.org/10.1016/j.ijrobp.2009.06.006
Shaw E et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47(2):291–298. https://doi.org/10.1016/s0360-3016(99)00507-6
留言 (0)